CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...